SPDR Biotech ETF +1.8%
Why now
Thesis: Biotech ETF strength suggests rotation into higher-beta healthcare
Catalyst to watch: Sustained sector inflows
Main risk: Risk appetite reverses
Why it matters
Biotech ETF strength suggests rotation into higher-beta healthcare, often a sign of improving risk appetite within defensives.
Details
SPDR Biotech ETF (XBI) moved +1.8% in the latest period (1d). Close: 161.03, prior: 158.23.
Sources
- yfinance · finance.yahoo.com · 2026-09-22 00:00 UTC